Effects of inhibitory rTMS on bladder function in Parkinson's disease patients
Identifieur interne : 002326 ( Main/Exploration ); précédent : 002325; suivant : 002327Effects of inhibitory rTMS on bladder function in Parkinson's disease patients
Auteurs : Livia Brusa [Italie] ; Enrico Finazzi Agr [Italie] ; Filomena Petta [Italie] ; Francesco Sciobica [Italie] ; Sara Torriero [Italie] ; Emanuele Lo Gerfo [Italie] ; Cesare Iani [Italie] ; Paolo Stanzione [Italie] ; Giacomo Koch [Italie]Source :
- Movement Disorders [ 0885-3185 ] ; 2009-02-15.
Descripteurs français
- Pascal (Inist)
- Wicri :
- topic : Homme.
English descriptors
- KwdEn :
- Aged, Antiparkinson Agents (therapeutic use), Bladder disease, Bladder function, Female, Human, Humans, Levodopa (therapeutic use), Male, Middle Aged, Nervous system diseases, Parkinson Disease (drug therapy), Parkinson Disease (epidemiology), Parkinson disease, Parkinson's disease, Prostatic Neoplasms (diagnosis), Prostatic Neoplasms (epidemiology), Questionnaires, Severity of Illness Index, Time Factors, Transcranial Magnetic Stimulation (methods), Transcranial magnetic stimulation, Urinary Bladder, Overactive (epidemiology), Urinary Bladder, Overactive (physiopathology), Urinary Bladder, Overactive (therapy), Urodynamics, bladder functions, rTMS, transcranial magnetic stimulation, urodynamic.
- MESH :
- chemical , therapeutic use : Antiparkinson Agents, Levodopa.
- diagnosis : Prostatic Neoplasms.
- drug therapy : Parkinson Disease.
- epidemiology : Parkinson Disease, Prostatic Neoplasms, Urinary Bladder, Overactive.
- methods : Transcranial Magnetic Stimulation.
- physiopathology : Urinary Bladder, Overactive.
- therapy : Urinary Bladder, Overactive.
- Aged, Female, Humans, Male, Middle Aged, Questionnaires, Severity of Illness Index, Time Factors, Urodynamics.
Abstract
Patients affected by Parkinson's disease (PD) may present with lower urinary tract (LUT) dysfunction characterized by involuntary detrusor overactivity. We evaluated possible impact of a 2‐week course of low frequency 1 Hz repetitive transcranial magnetic stimulation (rTMS) on LUT behavior in eight advanced PD patients complaining of urinary disturbances. We tested the effects of rTMS measuring urodynamic examination and the International Prostate Symptoms Score (IPSS) questionnaire, used for evaluation of subjective LUTS. rTMS was able to improve temporarily LUT behavior in PD patients, increasing bladder capacity and the first sensation of filling phase. Moreover, a reduction of IPSS score was noticed, due to an improvement on filling phase symptoms. The beneficial effects assessed with the IPSS lasted for up to 2 weeks after the end of the stimulation. rTMS seems to be an effective, noninvasive alternative treatment for PD patients with urinary disturbances. © 2009 Movement Disorder Society
Url:
DOI: 10.1002/mds.22434
Affiliations:
Links toward previous steps (curation, corpus...)
- to stream Istex, to step Corpus: 001D64
- to stream Istex, to step Curation: 001D64
- to stream Istex, to step Checkpoint: 000F28
- to stream PubMed, to step Corpus: 001E74
- to stream PubMed, to step Curation: 001E74
- to stream PubMed, to step Checkpoint: 001E30
- to stream Ncbi, to step Merge: 002490
- to stream Ncbi, to step Curation: 002490
- to stream Ncbi, to step Checkpoint: 002490
- to stream Main, to step Merge: 002B87
- to stream PascalFrancis, to step Corpus: 000F52
- to stream PascalFrancis, to step Curation: 001D67
- to stream PascalFrancis, to step Checkpoint: 000E92
- to stream Main, to step Merge: 002F89
- to stream Main, to step Curation: 002326
Le document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">Effects of inhibitory rTMS on bladder function in Parkinson's disease patients</title><author><name sortKey="Brusa, Livia" sort="Brusa, Livia" uniqKey="Brusa L" first="Livia" last="Brusa">Livia Brusa</name></author><author><name sortKey="Agr, Enrico Finazzi" sort="Agr, Enrico Finazzi" uniqKey="Agr E" first="Enrico Finazzi" last="Agr">Enrico Finazzi Agr</name></author><author><name sortKey="Petta, Filomena" sort="Petta, Filomena" uniqKey="Petta F" first="Filomena" last="Petta">Filomena Petta</name></author><author><name sortKey="Sciobica, Francesco" sort="Sciobica, Francesco" uniqKey="Sciobica F" first="Francesco" last="Sciobica">Francesco Sciobica</name></author><author><name sortKey="Torriero, Sara" sort="Torriero, Sara" uniqKey="Torriero S" first="Sara" last="Torriero">Sara Torriero</name></author><author><name sortKey="Lo Gerfo, Emanuele" sort="Lo Gerfo, Emanuele" uniqKey="Lo Gerfo E" first="Emanuele" last="Lo Gerfo">Emanuele Lo Gerfo</name></author><author><name sortKey="Iani, Cesare" sort="Iani, Cesare" uniqKey="Iani C" first="Cesare" last="Iani">Cesare Iani</name></author><author><name sortKey="Stanzione, Paolo" sort="Stanzione, Paolo" uniqKey="Stanzione P" first="Paolo" last="Stanzione">Paolo Stanzione</name></author><author><name sortKey="Koch, Giacomo" sort="Koch, Giacomo" uniqKey="Koch G" first="Giacomo" last="Koch">Giacomo Koch</name></author></titleStmt><publicationStmt><idno type="wicri:source">ISTEX</idno><idno type="RBID">ISTEX:4E226777FDFDA9BEFC12BD7AD65AD39A39C2B144</idno><date when="2009" year="2009">2009</date><idno type="doi">10.1002/mds.22434</idno><idno type="url">https://api.istex.fr/document/4E226777FDFDA9BEFC12BD7AD65AD39A39C2B144/fulltext/pdf</idno><idno type="wicri:Area/Istex/Corpus">001D64</idno><idno type="wicri:Area/Istex/Curation">001D64</idno><idno type="wicri:Area/Istex/Checkpoint">000F28</idno><idno type="wicri:doubleKey">0885-3185:2009:Brusa L:effects:of:inhibitory</idno><idno type="wicri:source">PubMed</idno><idno type="RBID">pubmed:19133657</idno><idno type="wicri:Area/PubMed/Corpus">001E74</idno><idno type="wicri:Area/PubMed/Curation">001E74</idno><idno type="wicri:Area/PubMed/Checkpoint">001E30</idno><idno type="wicri:Area/Ncbi/Merge">002490</idno><idno type="wicri:Area/Ncbi/Curation">002490</idno><idno type="wicri:Area/Ncbi/Checkpoint">002490</idno><idno type="wicri:Area/Main/Merge">002B87</idno><idno type="wicri:source">INIST</idno><idno type="RBID">Pascal:09-0136805</idno><idno type="wicri:Area/PascalFrancis/Corpus">000F52</idno><idno type="wicri:Area/PascalFrancis/Curation">001D67</idno><idno type="wicri:Area/PascalFrancis/Checkpoint">000E92</idno><idno type="wicri:doubleKey">0885-3185:2009:Brusa L:effects:of:inhibitory</idno><idno type="wicri:Area/Main/Merge">002F89</idno><idno type="wicri:Area/Main/Curation">002326</idno><idno type="wicri:Area/Main/Exploration">002326</idno></publicationStmt><sourceDesc><biblStruct><analytic><title level="a" type="main" xml:lang="en">Effects of inhibitory rTMS on bladder function in Parkinson's disease patients</title><author><name sortKey="Brusa, Livia" sort="Brusa, Livia" uniqKey="Brusa L" first="Livia" last="Brusa">Livia Brusa</name><affiliation wicri:level="3"><country>Italie</country><placeName><settlement type="city">Rome</settlement><region nuts="2">Latium</region></placeName><wicri:orgArea>UOC Neurologia, Ospedale S. Eugenio</wicri:orgArea></affiliation></author><author><name sortKey="Agr, Enrico Finazzi" sort="Agr, Enrico Finazzi" uniqKey="Agr E" first="Enrico Finazzi" last="Agr">Enrico Finazzi Agr</name><affiliation wicri:level="3"><country>Italie</country><placeName><settlement type="city">Rome</settlement><region nuts="2">Latium</region></placeName><wicri:orgArea>Clinica Urologica, Università di Roma Tor Vergata</wicri:orgArea></affiliation></author><author><name sortKey="Petta, Filomena" sort="Petta, Filomena" uniqKey="Petta F" first="Filomena" last="Petta">Filomena Petta</name><affiliation wicri:level="3"><country>Italie</country><placeName><settlement type="city">Rome</settlement><region nuts="2">Latium</region></placeName><wicri:orgArea>Clinica Urologica, Università di Roma Tor Vergata</wicri:orgArea></affiliation></author><author><name sortKey="Sciobica, Francesco" sort="Sciobica, Francesco" uniqKey="Sciobica F" first="Francesco" last="Sciobica">Francesco Sciobica</name><affiliation wicri:level="3"><country>Italie</country><placeName><settlement type="city">Rome</settlement><region nuts="2">Latium</region></placeName><wicri:orgArea>Clinica Urologica, Università di Roma Tor Vergata</wicri:orgArea></affiliation></author><author><name sortKey="Torriero, Sara" sort="Torriero, Sara" uniqKey="Torriero S" first="Sara" last="Torriero">Sara Torriero</name><affiliation wicri:level="3"><country>Italie</country><placeName><settlement type="city">Rome</settlement><region nuts="2">Latium</region></placeName><wicri:orgArea>Fondazione Santa Lucia IRCCS</wicri:orgArea></affiliation></author><author><name sortKey="Lo Gerfo, Emanuele" sort="Lo Gerfo, Emanuele" uniqKey="Lo Gerfo E" first="Emanuele" last="Lo Gerfo">Emanuele Lo Gerfo</name><affiliation wicri:level="3"><country>Italie</country><placeName><settlement type="city">Rome</settlement><region nuts="2">Latium</region></placeName><wicri:orgArea>Fondazione Santa Lucia IRCCS</wicri:orgArea></affiliation></author><author><name sortKey="Iani, Cesare" sort="Iani, Cesare" uniqKey="Iani C" first="Cesare" last="Iani">Cesare Iani</name><affiliation wicri:level="3"><country>Italie</country><placeName><settlement type="city">Rome</settlement><region nuts="2">Latium</region></placeName><wicri:orgArea>UOC Neurologia, Ospedale S. Eugenio</wicri:orgArea></affiliation></author><author><name sortKey="Stanzione, Paolo" sort="Stanzione, Paolo" uniqKey="Stanzione P" first="Paolo" last="Stanzione">Paolo Stanzione</name><affiliation wicri:level="3"><country>Italie</country><placeName><settlement type="city">Rome</settlement><region nuts="2">Latium</region></placeName><wicri:orgArea>Fondazione Santa Lucia IRCCS</wicri:orgArea></affiliation><affiliation wicri:level="3"><country xml:lang="fr">Italie</country><wicri:regionArea>Clinica Neurologica, Dipartimento di Neuroscienze, Università di Roma Tor Vergata, Rome</wicri:regionArea><placeName><settlement type="city">Rome</settlement><region nuts="2">Latium</region></placeName></affiliation></author><author><name sortKey="Koch, Giacomo" sort="Koch, Giacomo" uniqKey="Koch G" first="Giacomo" last="Koch">Giacomo Koch</name><affiliation wicri:level="3"><country>Italie</country><placeName><settlement type="city">Rome</settlement><region nuts="2">Latium</region></placeName><wicri:orgArea>Fondazione Santa Lucia IRCCS</wicri:orgArea></affiliation><affiliation wicri:level="3"><country xml:lang="fr">Italie</country><wicri:regionArea>Clinica Neurologica, Dipartimento di Neuroscienze, Università di Roma Tor Vergata, Rome</wicri:regionArea><placeName><settlement type="city">Rome</settlement><region nuts="2">Latium</region></placeName></affiliation></author></analytic><monogr></monogr><series><title level="j">Movement Disorders</title><title level="j" type="abbrev">Mov. Disord.</title><idno type="ISSN">0885-3185</idno><idno type="eISSN">1531-8257</idno><imprint><publisher>Wiley Subscription Services, Inc., A Wiley Company</publisher><pubPlace>Hoboken</pubPlace><date type="published" when="2009-02-15">2009-02-15</date><biblScope unit="vol">24</biblScope><biblScope unit="issue">3</biblScope><biblScope unit="page" from="445">445</biblScope><biblScope unit="page" to="447">447</biblScope></imprint><idno type="ISSN">0885-3185</idno></series><idno type="istex">4E226777FDFDA9BEFC12BD7AD65AD39A39C2B144</idno><idno type="DOI">10.1002/mds.22434</idno><idno type="ArticleID">MDS22434</idno></biblStruct></sourceDesc><seriesStmt><idno type="ISSN">0885-3185</idno></seriesStmt></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Aged</term><term>Antiparkinson Agents (therapeutic use)</term><term>Bladder disease</term><term>Bladder function</term><term>Female</term><term>Human</term><term>Humans</term><term>Levodopa (therapeutic use)</term><term>Male</term><term>Middle Aged</term><term>Nervous system diseases</term><term>Parkinson Disease (drug therapy)</term><term>Parkinson Disease (epidemiology)</term><term>Parkinson disease</term><term>Parkinson's disease</term><term>Prostatic Neoplasms (diagnosis)</term><term>Prostatic Neoplasms (epidemiology)</term><term>Questionnaires</term><term>Severity of Illness Index</term><term>Time Factors</term><term>Transcranial Magnetic Stimulation (methods)</term><term>Transcranial magnetic stimulation</term><term>Urinary Bladder, Overactive (epidemiology)</term><term>Urinary Bladder, Overactive (physiopathology)</term><term>Urinary Bladder, Overactive (therapy)</term><term>Urodynamics</term><term>bladder functions</term><term>rTMS</term><term>transcranial magnetic stimulation</term><term>urodynamic</term></keywords><keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en"><term>Antiparkinson Agents</term><term>Levodopa</term></keywords><keywords scheme="MESH" qualifier="diagnosis" xml:lang="en"><term>Prostatic Neoplasms</term></keywords><keywords scheme="MESH" qualifier="drug therapy" xml:lang="en"><term>Parkinson Disease</term></keywords><keywords scheme="MESH" qualifier="epidemiology" xml:lang="en"><term>Parkinson Disease</term><term>Prostatic Neoplasms</term><term>Urinary Bladder, Overactive</term></keywords><keywords scheme="MESH" qualifier="methods" xml:lang="en"><term>Transcranial Magnetic Stimulation</term></keywords><keywords scheme="MESH" qualifier="physiopathology" xml:lang="en"><term>Urinary Bladder, Overactive</term></keywords><keywords scheme="MESH" qualifier="therapy" xml:lang="en"><term>Urinary Bladder, Overactive</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Aged</term><term>Female</term><term>Humans</term><term>Male</term><term>Middle Aged</term><term>Questionnaires</term><term>Severity of Illness Index</term><term>Time Factors</term><term>Urodynamics</term></keywords><keywords scheme="Pascal" xml:lang="fr"><term>Fonction vésicale</term><term>Homme</term><term>Maladie de Parkinson</term><term>Pathologie de la vessie</term><term>Pathologie du système nerveux</term><term>Stimulation magnétique transcrânienne</term></keywords><keywords scheme="Wicri" type="topic" xml:lang="fr"><term>Homme</term></keywords></textClass><langUsage><language ident="en">en</language></langUsage></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Patients affected by Parkinson's disease (PD) may present with lower urinary tract (LUT) dysfunction characterized by involuntary detrusor overactivity. We evaluated possible impact of a 2‐week course of low frequency 1 Hz repetitive transcranial magnetic stimulation (rTMS) on LUT behavior in eight advanced PD patients complaining of urinary disturbances. We tested the effects of rTMS measuring urodynamic examination and the International Prostate Symptoms Score (IPSS) questionnaire, used for evaluation of subjective LUTS. rTMS was able to improve temporarily LUT behavior in PD patients, increasing bladder capacity and the first sensation of filling phase. Moreover, a reduction of IPSS score was noticed, due to an improvement on filling phase symptoms. The beneficial effects assessed with the IPSS lasted for up to 2 weeks after the end of the stimulation. rTMS seems to be an effective, noninvasive alternative treatment for PD patients with urinary disturbances. © 2009 Movement Disorder Society</div></front></TEI><affiliations><list><country><li>Italie</li></country><region><li>Latium</li></region><settlement><li>Rome</li></settlement></list><tree><country name="Italie"><region name="Latium"><name sortKey="Brusa, Livia" sort="Brusa, Livia" uniqKey="Brusa L" first="Livia" last="Brusa">Livia Brusa</name></region><name sortKey="Agr, Enrico Finazzi" sort="Agr, Enrico Finazzi" uniqKey="Agr E" first="Enrico Finazzi" last="Agr">Enrico Finazzi Agr</name><name sortKey="Iani, Cesare" sort="Iani, Cesare" uniqKey="Iani C" first="Cesare" last="Iani">Cesare Iani</name><name sortKey="Koch, Giacomo" sort="Koch, Giacomo" uniqKey="Koch G" first="Giacomo" last="Koch">Giacomo Koch</name><name sortKey="Koch, Giacomo" sort="Koch, Giacomo" uniqKey="Koch G" first="Giacomo" last="Koch">Giacomo Koch</name><name sortKey="Lo Gerfo, Emanuele" sort="Lo Gerfo, Emanuele" uniqKey="Lo Gerfo E" first="Emanuele" last="Lo Gerfo">Emanuele Lo Gerfo</name><name sortKey="Petta, Filomena" sort="Petta, Filomena" uniqKey="Petta F" first="Filomena" last="Petta">Filomena Petta</name><name sortKey="Sciobica, Francesco" sort="Sciobica, Francesco" uniqKey="Sciobica F" first="Francesco" last="Sciobica">Francesco Sciobica</name><name sortKey="Stanzione, Paolo" sort="Stanzione, Paolo" uniqKey="Stanzione P" first="Paolo" last="Stanzione">Paolo Stanzione</name><name sortKey="Stanzione, Paolo" sort="Stanzione, Paolo" uniqKey="Stanzione P" first="Paolo" last="Stanzione">Paolo Stanzione</name><name sortKey="Torriero, Sara" sort="Torriero, Sara" uniqKey="Torriero S" first="Sara" last="Torriero">Sara Torriero</name></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 002326 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 002326 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Santé
|area= MovDisordV3
|flux= Main
|étape= Exploration
|type= RBID
|clé= ISTEX:4E226777FDFDA9BEFC12BD7AD65AD39A39C2B144
|texte= Effects of inhibitory rTMS on bladder function in Parkinson's disease patients
}}
| This area was generated with Dilib version V0.6.23. |  |